Avicanna Inc. (AVCN.TO)

CAD 0.24

(0.0%)

Operating Expenses Summary of Avicanna Inc.

Avicanna Inc.'s latest annual operating expenses in 2023 was 14.59 Million CAD , up 23.73% from previous year.
Avicanna Inc.'s latest quarterly operating expenses in 2024 Q1 was 3.66 Million CAD , down -14.96% from previous quarter.
Avicanna Inc. reported a annual operating expenses of 11.52 Million CAD in annual operating expenses 2022, down -19.09% from previous year.
Avicanna Inc. reported a annual operating expenses of 14.24 Million CAD in annual operating expenses 2021, down -22.66% from previous year.
Avicanna Inc. reported a quarterly operating expenses of 4.45 Million CAD for 2024 Q2, up 23.17% from previous quarter.
Avicanna Inc. reported a quarterly operating expenses of 4.3 Million CAD for 2023 Q4, up 2.29% from previous quarter.

Annual Operating Expenses Chart of Avicanna Inc. (2023 - 2016)

Historical Annual Operating Expenses of Avicanna Inc. (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	14.59 Million CAD	23.73%
2022	11.52 Million CAD	-19.09%
2021	14.24 Million CAD	-22.66%
2020	18.41 Million CAD	-21.0%
2019	23.31 Million CAD	176.19%
2018	8.44 Million CAD	223.17%
2017	2.61 Million CAD	8656.2%
2016	29.83 Thousand CAD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	3.66 Million CAD	-14.96%
2024 Q2	4.45 Million CAD	23.17%
2023 Q4	4.3 Million CAD	2.29%
2023 FY	14.26 Million CAD	23.73%
2023 Q3	4.2 Million CAD	25.75%
2023 Q2	3.34 Million CAD	13.49%
2023 Q1	2.94 Million CAD	-1.71%
2022 Q1	2.45 Million CAD	-50.02%
2022 FY	11.52 Million CAD	-19.09%
2022 Q4	3 Million CAD	2.68%
2022 Q3	2.92 Million CAD	-7.21%
2022 Q2	3.14 Million CAD	28.45%
2021 Q2	2.93 Million CAD	-11.47%
2021 FY	14.24 Million CAD	-22.66%
2021 Q1	3.31 Million CAD	-39.56%
2021 Q4	4.9 Million CAD	59.21%
2021 Q3	3.08 Million CAD	4.88%
2020 Q3	4.36 Million CAD	-3.81%
2020 Q2	4.53 Million CAD	12.39%
2020 FY	18.41 Million CAD	-21.0%
2020 Q1	4.03 Million CAD	-50.92%
2020 Q4	5.49 Million CAD	25.95%
2019 Q4	8.21 Million CAD	31.21%
2019 Q3	6.26 Million CAD	24.09%
2019 FY	23.31 Million CAD	176.19%
2019 Q2	5.04 Million CAD	33.23%
2019 Q1	3.78 Million CAD	7.99%
2018 Q2	1.47 Million CAD	7.55%
2018 FY	8.44 Million CAD	223.17%
2018 Q4	3.5 Million CAD	75.42%
2018 Q3	1.99 Million CAD	35.57%
2018 Q1	1.37 Million CAD	14.5%
2017 Q4	1.19 Million CAD	109.6%
2017 FY	2.61 Million CAD	8656.2%
2017 Q3	571.46 Thousand CAD	0.0%
2016 FY	29.83 Thousand CAD	0.0%

Peer Operating Expenses Comparison of Avicanna Inc.

Name	Operating Expenses	Operating Expenses Difference
Aurora Cannabis Inc.	158.53 Million CAD	90.796%
Avant Brands Inc.	5.65 Million CAD	-157.849%
Cardiol Therapeutics Inc.	29.53 Million CAD	50.599%
Crescita Therapeutics Inc.	12.32 Million CAD	-18.439%
Knight Therapeutics Inc.	155.54 Million CAD	90.619%
MediPharm Labs Corp.	23.08 Million CAD	36.786%
OrganiGram Holdings Inc.	277.81 Million CAD	94.748%
Canopy Growth Corporation	308.61 Million CAD	95.272%
Willow Biosciences Inc.	7.55 Million CAD	-93.165%
Auxly Cannabis Group Inc.	40.28 Million CAD	63.776%